> top > docs > PMC:3342329 > spans > 23409-25170 > annotations

PMC:3342329 / 23409-25170 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T8979 1748-1752 Protein denotes CCR5
T8978 1605-1609 Protein denotes CCR5
T8977 1565-1569 Protein denotes CCR5
T8976 1476-1482 Protein denotes MIP-1α
T8975 1305-1309 Protein denotes CCR5
T8974 1284-1288 Protein denotes CCR5
T8973 1166-1170 Protein denotes CCR5
T8972 872-876 Protein denotes CCR5
T8971 761-765 Protein denotes CCR5
T8970 557-561 Protein denotes CCR5
T8969 496-506 Gene_expression denotes production
T8968 491-495 Protein denotes CCL5
T8967 456-460 Protein denotes CCL5
T8966 451-455 Protein denotes CCR5
T8965 305-309 Protein denotes CCR5
T8964 190-194 Protein denotes CCR5
T8963 128-132 Protein denotes CCR5
T8962 101-105 Protein denotes CCR5
T8961 0-4 Protein denotes CCR5
T8896 1748-1752 Protein denotes CCR5
T8895 1605-1609 Protein denotes CCR5
T8894 1565-1569 Protein denotes CCR5
T8893 1476-1482 Protein denotes MIP-1α
T8892 1305-1309 Protein denotes CCR5
T8891 1284-1288 Protein denotes CCR5
T8890 1166-1170 Protein denotes CCR5
T8889 872-876 Protein denotes CCR5
T8888 761-765 Protein denotes CCR5
T8887 557-561 Protein denotes CCR5
T8886 491-495 Protein denotes CCL5
T8885 456-460 Protein denotes CCL5
T8884 451-455 Protein denotes CCR5
T8883 305-309 Protein denotes CCR5
T8882 190-194 Protein denotes CCR5
T8881 128-132 Protein denotes CCR5
T8880 101-105 Protein denotes CCR5
T8879 0-4 Protein denotes CCR5
R5910 T8968 T8969 themeOf CCL5,production

testone

Id Subject Object Predicate Lexical cue
T8838 1187-1195 Negative_regulation denotes decrease
T8837 496-506 Gene_expression denotes production
T8836 482-490 Negative_regulation denotes reducing
T8803 1748-1752 Protein denotes CCR5
T8802 1605-1609 Protein denotes CCR5
T8801 1565-1569 Protein denotes CCR5
T8800 1476-1482 Protein denotes MIP-1α
T8799 1305-1309 Protein denotes CCR5
T8798 1284-1288 Protein denotes CCR5
T8797 1166-1170 Protein denotes CCR5
T8796 872-876 Protein denotes CCR5
T8795 761-765 Protein denotes CCR5
T8794 557-561 Protein denotes CCR5
T8793 491-495 Protein denotes CCL5
T8792 456-460 Protein denotes CCL5
T8791 451-455 Protein denotes CCR5
T8790 305-309 Protein denotes CCR5
T8789 190-194 Protein denotes CCR5
T8788 128-132 Protein denotes CCR5
T8787 101-105 Protein denotes CCR5
T8786 0-4 Protein denotes CCR5
R5882 T8793 T8837 themeOf CCL5,production
R5893 T8837 T8836 themeOf production,reducing

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T11158 1748-1752 Protein denotes CCR5
T11157 1605-1609 Protein denotes CCR5
T11156 1565-1569 Protein denotes CCR5
T11155 1476-1482 Protein denotes MIP-1α
T11154 1305-1309 Protein denotes CCR5
T11153 1284-1288 Protein denotes CCR5
T11152 1166-1170 Protein denotes CCR5
T11151 872-876 Protein denotes CCR5
T11150 761-765 Protein denotes CCR5
T11149 557-561 Protein denotes CCR5
T11148 491-495 Protein denotes CCL5
T11147 456-460 Protein denotes CCL5
T11146 451-455 Protein denotes CCR5
T11145 305-309 Protein denotes CCR5
T11144 190-194 Protein denotes CCR5
T11143 128-132 Protein denotes CCR5
T11142 101-105 Protein denotes CCR5
T11141 0-4 Protein denotes CCR5
T11188 1548-1557 Positive_regulation denotes increased
T11187 562-571 Negative_regulation denotes inhibitor
T11186 437-447 Negative_regulation denotes disruption
T11185 496-506 Gene_expression denotes production
T11184 482-490 Negative_regulation denotes reducing
T11183 310-317 Negative_regulation denotes absence
R7402 T11145 T11183 themeOf CCR5,absence
R7403 T11147 T11186 themeOf CCL5,disruption
R7404 T11148 T11185 themeOf CCL5,production
R7405 T11149 T11187 themeOf CCR5,inhibitor
R7407 T11155 T11188 themeOf MIP-1α,increased
R7424 T11185 T11184 themeOf production,reducing

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T10830 1748-1752 Protein denotes CCR5
T10829 1605-1609 Protein denotes CCR5
T10828 1565-1569 Protein denotes CCR5
T10827 1476-1482 Protein denotes MIP-1α
T10826 1305-1309 Protein denotes CCR5
T10825 1284-1288 Protein denotes CCR5
T10824 1166-1170 Protein denotes CCR5
T10823 872-876 Protein denotes CCR5
T10822 761-765 Protein denotes CCR5
T10821 557-561 Protein denotes CCR5
T10820 491-495 Protein denotes CCL5
T10819 456-460 Protein denotes CCL5
T10818 451-455 Protein denotes CCR5
T10817 305-309 Protein denotes CCR5
T10816 190-194 Protein denotes CCR5
T10815 128-132 Protein denotes CCR5
T10814 101-105 Protein denotes CCR5
T10813 0-4 Protein denotes CCR5
T10863 1548-1557 Positive_regulation denotes increased
T10862 562-571 Negative_regulation denotes inhibitor
T10861 496-506 Gene_expression denotes production
T10860 482-490 Negative_regulation denotes reducing
T10859 310-317 Negative_regulation denotes absence
R7317 T10817 T10859 themeOf CCR5,absence
R7318 T10820 T10861 themeOf CCL5,production
R7319 T10821 T10862 themeOf CCR5,inhibitor
R7320 T10827 T10863 themeOf MIP-1α,increased
R7332 T10861 T10860 themeOf production,reducing

2_test

Id Subject Object Predicate Lexical cue
22567084-12682253-91707051 142-144 12682253 denotes 10
22567084-21276984-91707052 389-391 21276984 denotes 48
22567084-19155524-91707053 681-682 19155524 denotes 9

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T10413 1436-1444 NN denotes cytokine
T10412 1432-1435 DT denotes the
T10411 1429-1431 IN denotes in
T10410 1427-1428 -COMMA- denotes ,
T10409 1419-1427 RB denotes together
T10408 1413-1418 VB denotes Taken
T10407 1400-1411 NN denotes progression
T10406 1393-1399 NN denotes cancer
T10405 1390-1392 IN denotes of
T10404 1379-1389 NN denotes inhibition
T10403 1375-1378 DT denotes the
T10402 1370-1374 IN denotes with
T10401 1360-1369 VB denotes connected
T10400 1357-1359 VB denotes be
T10399 1353-1356 MD denotes may
T10398 1351-1352 -COMMA- denotes ,
T10397 1342-1351 NN denotes tolerance
T10396 1335-1341 JJ denotes immune
T10395 1329-1334 NN denotes tumor
T10394 1319-1328 VB denotes involving
T10393 1317-1318 -COMMA- denotes ,
T10392 1313-1317 NN denotes mice
T10391 1305-1312 NN denotes CCR5−/−
T10390 1301-1304 DT denotes the
T10389 1297-1300 CC denotes and
T10388 1292-1296 NN denotes mice
T10387 1284-1291 JJ denotes CCR5+/+
T10386 1280-1283 DT denotes the
T10385 1272-1279 IN denotes between
T10384 1263-1271 NN denotes response
T10383 1256-1262 JJ denotes immune
T10382 1252-1255 DT denotes the
T10381 1249-1251 IN denotes of
T10380 1237-1248 NN denotes differences
T10379 1231-1236 DT denotes These
T10378 1224-1229 NN denotes cells
T10377 1215-1223 NN denotes melanoma
T10376 1210-1214 IN denotes with
T10375 1201-1209 VB denotes injected
T10374 1196-1200 WRB denotes when
T10373 1187-1195 VB denotes decrease
T10372 1183-1186 RB denotes not
T10371 1179-1182 VB denotes did
T10370 1174-1178 NN denotes mice
T10369 1166-1173 NN denotes CCR5−/−
T10368 1162-1165 DT denotes the
T10367 1159-1161 IN denotes of
T10366 1147-1158 NN denotes lymphocytes
T10365 1143-1146 DT denotes the
T10364 1139-1142 CC denotes But
T10363 1132-1137 NN denotes cells
T10362 1123-1131 NN denotes melanoma
T10361 1115-1122 IN denotes without
T10360 1109-1114 DT denotes those
T10359 1106-1108 TO denotes to
T10358 1097-1105 VB denotes compared
T10357 1089-1096 NN denotes tissues
T10356 1082-1088 NN denotes spleen
T10355 1079-1081 IN denotes in
T10354 1077-1078 -COMMA- denotes ,
T10353 1072-1077 NN denotes cells
T10352 1063-1071 NN denotes dendrite
T10351 1060-1062 IN denotes as
T10350 1055-1059 RB denotes well
T10349 1052-1054 RB denotes as
T10348 1050-1051 -COMMA- denotes ,
T10347 1049-1050 -RRB- denotes )
T10346 1044-1049 NN denotes cells
T10345 1041-1043 NN denotes NK
T10344 1032-1040 JJ denotes positive
T10343 1027-1031 NN denotes CD57
T10342 1026-1027 -LRB- denotes (
T10341 1020-1025 NN denotes cells
T10340 1013-1019 NN denotes killer
T10339 1005-1012 JJ denotes natural
T10338 1001-1004 CC denotes and
T10337 999-1000 -RRB- denotes )
T10336 994-999 NN denotes cells
T10335 982-993 NN denotes Lymphocytes
T10334 980-981 NN denotes T
T10333 967-979 JJ denotes CD8+positive
T10332 966-967 -LRB- denotes (
T10331 960-965 NN denotes cells
T10330 958-959 NN denotes T
T10329 948-957 JJ denotes cytotoxic
T10328 945-947 IN denotes of
T10327 938-944 NN denotes number
T10326 932-937 JJ denotes lower
T10325 930-931 DT denotes a
T10324 925-929 VB denotes have
T10323 914-924 RB denotes apparently
T10322 908-913 NN denotes cells
T10321 899-907 NN denotes melanoma
T10320 894-898 IN denotes with
T10319 885-893 VB denotes injected
T10318 880-884 NN denotes mice
T10317 872-879 JJ denotes CCR5+/+
T10316 868-871 DT denotes the
T10315 863-867 IN denotes that
T10314 857-862 VB denotes found
T10313 854-856 PRP denotes we
T10312 852-853 -COMMA- denotes ,
T10311 845-852 NN denotes finding
T10310 840-844 DT denotes this
T10309 837-839 TO denotes to
T10308 829-836 JJ denotes Similar
T10307 821-827 NN denotes escape
T10306 814-820 JJ denotes immune
T10305 811-813 IN denotes of
T10304 800-810 NN denotes inhibition
T10303 796-799 DT denotes the
T10302 791-795 IN denotes with
T10301 783-790 VB denotes related
T10300 780-782 VB denotes be
T10299 774-779 MD denotes could
T10298 769-773 NN denotes mice
T10297 761-768 NN denotes CCR5−/−
T10296 758-760 IN denotes in
T10295 751-757 NN denotes growth
T10294 745-750 NN denotes tumor
T10293 742-744 IN denotes of
T10292 731-741 NN denotes inhibition
T10291 726-730 IN denotes that
T10290 718-725 NN denotes premise
T10289 708-717 JJ denotes important
T10288 704-707 DT denotes the
T10287 696-703 VB denotes support
T10286 691-695 NN denotes data
T10285 685-690 DT denotes These
T10284 682-683 -RRB- denotes ]
T10283 681-682 CD denotes 9
T10282 680-681 -LRB- denotes [
T10281 675-679 NN denotes mice
T10280 667-674 NN denotes control
T10279 664-666 IN denotes in
T10278 656-663 JJ denotes smaller
T10277 652-655 VB denotes are
T10276 645-651 NN denotes tumors
T10275 640-644 IN denotes that
T10274 637-639 IN denotes so
T10273 630-636 NN denotes tumors
T10272 627-629 TO denotes to
T10271 617-626 NN denotes migration
T10270 615-616 -RRB- denotes )
T10269 610-615 NN denotes cells
T10268 608-609 NN denotes T
T10267 597-607 JJ denotes regulatory
T10266 596-597 -LRB- denotes (
T10265 591-595 NNP denotes Treg
T10264 583-590 VB denotes reduced
T10263 581-582 -COMMA- denotes ,
T10262 580-581 -RRB- denotes )
T10261 573-580 NN denotes TAK-779
T10260 572-573 -LRB- denotes (
T10259 562-571 NN denotes inhibitor
T10258 557-561 NN denotes CCR5
T10257 555-556 DT denotes a
T10256 552-554 IN denotes of
T10255 537-551 NN denotes administration
T10254 528-536 JJ denotes systemic
T10253 525-527 IN denotes by
T10252 522-524 CC denotes or
T10251 516-521 NN denotes cells
T10250 510-515 NN denotes tumor
T10249 507-509 IN denotes by
T10248 496-506 NN denotes production
T10247 491-495 NN denotes CCL5
T10246 482-490 VB denotes reducing
T10245 479-481 IN denotes by
T10244 472-478 CC denotes either
T10243 470-471 -COMMA- denotes ,
T10242 461-470 NN denotes signaling
T10241 451-460 NN denotes CCR5/CCL5
T10240 448-450 IN denotes of
T10239 437-447 NN denotes disruption
T10238 432-436 IN denotes that
T10237 422-431 VB denotes suggested
T10236 418-421 FW denotes al.
T10235 415-417 FW denotes et
T10234 412-414 NNP denotes MC
T10233 408-411 NNP denotes Tan
T10232 406-407 -COMMA- denotes ,
T10231 394-406 RB denotes Additionally
T10230 391-392 -RRB- denotes ]
T10229 389-391 CD denotes 48
T10228 388-389 -LRB- denotes [
T10227 375-387 NN denotes transduction
T10226 364-374 NN denotes adenovirus
T10225 361-363 TO denotes to
T10224 352-360 NN denotes response
T10223 345-351 JJ denotes immune
T10222 339-344 JJ denotes local
T10221 335-338 DT denotes the
T10220 327-334 VB denotes prevent
T10219 323-326 RB denotes not
T10218 318-322 VB denotes does
T10217 310-317 NN denotes absence
T10216 305-309 NN denotes CCR5
T10215 300-304 IN denotes that
T10214 294-299 VB denotes found
T10213 289-293 PRP denotes They
T10212 282-287 NN denotes model
T10211 271-281 NN denotes transplant
T10210 265-270 NN denotes islet
T10209 262-264 DT denotes an
T10208 259-261 IN denotes in
T10207 250-258 NN denotes function
T10206 244-249 NN denotes graft
T10205 240-243 CC denotes and
T10204 232-239 NN denotes vectors
T10203 221-231 NN denotes adenovirus
T10202 218-220 TO denotes to
T10201 209-217 NN denotes response
T10200 202-208 JJ denotes immune
T10199 198-201 DT denotes the
T10198 195-197 IN denotes on
T10468 1756-1760 NN denotes mice
T10467 1748-1755 NN denotes CCR5−/−
T10466 1745-1747 IN denotes in
T10465 1738-1744 NN denotes growth
T10464 1732-1737 NN denotes tumor
T10463 1728-1731 DT denotes the
T10462 1717-1727 VB denotes inhibiting
T10461 1714-1716 IN denotes in
T10460 1709-1713 NN denotes role
T10459 1699-1708 JJ denotes important
T10458 1696-1698 DT denotes an
T10457 1691-1695 VB denotes play
T10456 1685-1690 MD denotes could
T10455 1673-1684 NN denotes lymphocytes
T10454 1663-1672 JJ denotes cytotoxic
T10453 1652-1662 VB denotes associated
T10452 1646-1651 NN denotes tumor
T10451 1636-1645 VB denotes increased
T10450 1625-1635 RB denotes relatively
T10449 1623-1624 -COMMA- denotes ,
T10448 1619-1623 RB denotes Thus
T10447 1613-1617 NN denotes mice
T10446 1605-1612 JJ denotes CCR5+/+
T10445 1601-1604 DT denotes the
T10444 1598-1600 IN denotes in
T10443 1592-1597 DT denotes those
T10442 1587-1591 IN denotes with
T10441 1578-1586 VB denotes compared
T10440 1573-1577 NN denotes mice
T10439 1565-1572 NN denotes CCR5−/−
T10438 1561-1564 DT denotes the
T10437 1558-1560 IN denotes in
T10436 1548-1557 VB denotes increased
T10435 1544-1547 VB denotes was
T10434 1542-1543 -RRB- denotes )
T10433 1533-1542 NN denotes migration
T10432 1528-1532 NN denotes cell
T10431 1526-1527 NN denotes B
T10430 1522-1525 CC denotes and
T10429 1517-1521 NN denotes cell
T10428 1515-1516 NN denotes T
T10427 1512-1514 IN denotes of
T10426 1503-1511 NN denotes activity
T10425 1496-1502 JJ denotes potent
T10424 1494-1495 DT denotes a
T10423 1490-1493 VB denotes has
T10422 1484-1489 WDT denotes which
T10421 1483-1484 -LRB- denotes (
T10420 1476-1482 NN denotes MIP-1α
T10419 1473-1475 IN denotes of
T10418 1467-1472 NN denotes level
T10417 1463-1466 DT denotes the
T10416 1461-1462 -COMMA- denotes ,
T10415 1451-1461 NN denotes experiment
T10414 1445-1450 NN denotes array
T10197 190-194 NN denotes CCR5
T10196 187-189 IN denotes of
T10195 180-186 NN denotes effect
T10194 176-179 DT denotes the
T10193 167-175 VB denotes examined
T10192 164-166 NNP denotes RS
T10191 159-163 NNP denotes Sung
T10190 155-158 CC denotes and
T10189 153-154 NNP denotes J
T10188 147-152 NNP denotes Cheng
T10187 144-145 -RRB- denotes ]
T10186 142-144 CD denotes 10
T10185 141-142 -LRB- denotes [
T10184 136-140 NN denotes mice
T10183 128-135 NN denotes CCR5−/−
T10182 123-127 IN denotes with
T10181 114-122 VB denotes compared
T10180 109-113 NN denotes mice
T10179 101-108 JJ denotes CCR5+/+
T10178 98-100 IN denotes in
T10177 90-97 NN denotes vaccine
T10176 85-89 NN denotes cell
T10175 76-84 NN denotes dendrite
T10174 74-75 DT denotes a
T10173 71-73 IN denotes of
T10172 62-70 NN denotes efficacy
T10171 58-61 DT denotes the
T10170 49-57 VB denotes inhibits
T10169 45-48 CC denotes and
T10168 39-44 NN denotes model
T10167 33-38 JJ denotes local
T10166 31-32 DT denotes a
T10165 28-30 IN denotes in
T10164 21-27 NN denotes growth
T10163 15-20 NN denotes tumor
T10162 5-14 VB denotes increases
T10161 0-4 NN denotes CCR5
R6720 T10161 T10162 arg1Of CCR5,increases
R6721 T10161 T10170 arg1Of CCR5,inhibits
R6722 T10162 T10165 arg1Of increases,in
R6723 T10162 T10169 arg1Of increases,and
R6724 T10164 T10162 arg2Of growth,increases
R6725 T10164 T10163 arg1Of growth,tumor
R6726 T10168 T10165 arg2Of model,in
R6727 T10168 T10166 arg1Of model,a
R6728 T10168 T10167 arg1Of model,local
R6729 T10170 T10169 arg2Of inhibits,and
R6730 T10172 T10170 arg2Of efficacy,inhibits
R6731 T10172 T10171 arg1Of efficacy,the
R6732 T10172 T10173 arg1Of efficacy,of
R6733 T10172 T10178 arg1Of efficacy,in
R6734 T10177 T10173 arg2Of vaccine,of
R6735 T10177 T10174 arg1Of vaccine,a
R6736 T10177 T10175 arg1Of vaccine,dendrite
R6737 T10177 T10176 arg1Of vaccine,cell
R6738 T10180 T10178 arg2Of mice,in
R6739 T10180 T10179 arg1Of mice,CCR5+/+
R6740 T10180 T10181 arg1Of mice,compared
R6741 T10182 T10181 arg2Of with,compared
R6742 T10184 T10182 arg2Of mice,with
R6743 T10184 T10183 arg1Of mice,CCR5−/−
R6744 T10184 T10185 arg1Of mice,[
R6745 T10186 T10185 arg2Of 10,[
R6746 T10187 T10185 arg3Of ],[
R6747 T10189 T10188 arg1Of J,Cheng
R6748 T10189 T10190 arg1Of J,and
R6749 T10190 T10193 arg1Of and,examined
R6750 T10192 T10190 arg2Of RS,and
R6751 T10192 T10191 arg1Of RS,Sung
R6752 T10193 T10208 arg1Of examined,in
R6753 T10195 T10193 arg2Of effect,examined
R6754 T10195 T10194 arg1Of effect,the
R6755 T10195 T10196 arg1Of effect,of
R6756 T10195 T10198 arg1Of effect,on
R6757 T10197 T10196 arg2Of CCR5,of
R6758 T10201 T10198 arg2Of response,on
R6759 T10201 T10199 arg1Of response,the
R6760 T10201 T10200 arg1Of response,immune
R6761 T10201 T10202 arg1Of response,to
R6762 T10204 T10203 arg1Of vectors,adenovirus
R6763 T10204 T10205 arg1Of vectors,and
R6764 T10205 T10202 arg2Of and,to
R6765 T10207 T10205 arg2Of function,and
R6766 T10207 T10206 arg1Of function,graft
R6767 T10212 T10208 arg2Of model,in
R6768 T10212 T10209 arg1Of model,an
R6769 T10212 T10210 arg1Of model,islet
R6770 T10212 T10211 arg1Of model,transplant
R6771 T10213 T10214 arg1Of They,found
R6772 T10217 T10216 arg1Of absence,CCR5
R6773 T10217 T10218 arg1Of absence,does
R6774 T10217 T10220 arg1Of absence,prevent
R6775 T10220 T10214 arg2Of prevent,found
R6776 T10220 T10215 arg1Of prevent,that
R6777 T10220 T10218 arg2Of prevent,does
R6778 T10220 T10219 arg1Of prevent,not
R6779 T10220 T10228 arg1Of prevent,[
R6780 T10224 T10220 arg2Of response,prevent
R6781 T10224 T10221 arg1Of response,the
R6782 T10224 T10222 arg1Of response,local
R6783 T10224 T10223 arg1Of response,immune
R6784 T10224 T10225 arg1Of response,to
R6785 T10227 T10225 arg2Of transduction,to
R6786 T10227 T10226 arg1Of transduction,adenovirus
R6787 T10229 T10228 arg2Of 48,[
R6788 T10230 T10228 arg3Of ],[
R6789 T10234 T10233 arg1Of MC,Tan
R6790 T10234 T10235 arg1Of MC,et
R6791 T10234 T10236 arg1Of MC,al.
R6792 T10234 T10237 arg1Of MC,suggested
R6793 T10237 T10231 arg1Of suggested,Additionally
R6794 T10237 T10232 arg1Of suggested,","
R6795 T10239 T10240 arg1Of disruption,of
R6796 T10239 T10243 arg1Of disruption,","
R6797 T10239 T10245 arg1Of disruption,by
R6798 T10239 T10253 arg1Of disruption,by
R6799 T10239 T10264 arg1Of disruption,reduced
R6800 T10242 T10240 arg2Of signaling,of
R6801 T10242 T10241 arg1Of signaling,CCR5/CCL5
R6802 T10245 T10244 arg1Of by,either
R6803 T10245 T10252 arg1Of by,or
R6804 T10246 T10245 arg2Of reducing,by
R6805 T10248 T10246 arg2Of production,reducing
R6806 T10248 T10247 arg1Of production,CCL5
R6807 T10248 T10249 arg1Of production,by
R6808 T10251 T10249 arg2Of cells,by
R6809 T10251 T10250 arg1Of cells,tumor
R6810 T10253 T10252 arg2Of by,or
R6811 T10255 T10253 arg2Of administration,by
R6812 T10255 T10254 arg1Of administration,systemic
R6813 T10255 T10256 arg1Of administration,of
R6814 T10259 T10256 arg2Of inhibitor,of
R6815 T10259 T10257 arg1Of inhibitor,a
R6816 T10259 T10258 arg1Of inhibitor,CCR5
R6817 T10259 T10260 arg1Of inhibitor,(
R6818 T10261 T10260 arg2Of TAK-779,(
R6819 T10262 T10260 arg3Of ),(
R6820 T10264 T10237 arg2Of reduced,suggested
R6821 T10264 T10238 arg1Of reduced,that
R6822 T10264 T10263 arg1Of reduced,","
R6823 T10264 T10274 arg1Of reduced,so
R6824 T10269 T10266 arg2Of cells,(
R6825 T10269 T10267 arg1Of cells,regulatory
R6826 T10269 T10268 arg1Of cells,T
R6827 T10270 T10266 arg3Of ),(
R6828 T10271 T10264 arg2Of migration,reduced
R6829 T10271 T10265 arg1Of migration,Treg
R6830 T10271 T10266 arg1Of migration,(
R6831 T10271 T10272 arg1Of migration,to
R6832 T10273 T10272 arg2Of tumors,to
R6833 T10274 T10275 arg1Of so,that
R6834 T10276 T10277 arg1Of tumors,are
R6835 T10276 T10278 arg1Of tumors,smaller
R6836 T10277 T10274 arg2Of are,so
R6837 T10278 T10277 arg2Of smaller,are
R6838 T10278 T10279 arg1Of smaller,in
R6839 T10281 T10279 arg2Of mice,in
R6840 T10281 T10280 arg1Of mice,control
R6841 T10281 T10282 arg1Of mice,[
R6842 T10283 T10282 arg2Of 9,[
R6843 T10284 T10282 arg3Of ],[
R6844 T10286 T10285 arg1Of data,These
R6845 T10286 T10287 arg1Of data,support
R6846 T10290 T10287 arg2Of premise,support
R6847 T10290 T10288 arg1Of premise,the
R6848 T10290 T10289 arg1Of premise,important
R6849 T10292 T10293 arg1Of inhibition,of
R6850 T10292 T10299 arg1Of inhibition,could
R6851 T10292 T10300 arg1Of inhibition,be
R6852 T10292 T10301 arg2Of inhibition,related
R6853 T10295 T10293 arg2Of growth,of
R6854 T10295 T10294 arg1Of growth,tumor
R6855 T10295 T10296 arg1Of growth,in
R6856 T10298 T10296 arg2Of mice,in
R6857 T10298 T10297 arg1Of mice,CCR5−/−
R6858 T10301 T10290 arg2Of related,premise
R6859 T10301 T10291 arg1Of related,that
R6860 T10301 T10299 arg2Of related,could
R6861 T10301 T10300 arg2Of related,be
R6862 T10301 T10302 arg1Of related,with
R6863 T10304 T10302 arg2Of inhibition,with
R6864 T10304 T10303 arg1Of inhibition,the
R6865 T10304 T10305 arg1Of inhibition,of
R6866 T10307 T10305 arg2Of escape,of
R6867 T10307 T10306 arg1Of escape,immune
R6868 T10308 T10309 arg1Of Similar,to
R6869 T10311 T10309 arg2Of finding,to
R6870 T10311 T10310 arg1Of finding,this
R6871 T10313 T10314 arg1Of we,found
R6872 T10314 T10308 arg1Of found,Similar
R6873 T10314 T10312 arg1Of found,","
R6874 T10318 T10316 arg1Of mice,the
R6875 T10318 T10317 arg1Of mice,CCR5+/+
R6876 T10318 T10319 arg2Of mice,injected
R6877 T10318 T10324 arg1Of mice,have
R6878 T10319 T10320 arg1Of injected,with
R6879 T10322 T10320 arg2Of cells,with
R6880 T10322 T10321 arg1Of cells,melanoma
R6881 T10324 T10314 arg2Of have,found
R6882 T10324 T10315 arg1Of have,that
R6883 T10324 T10323 arg1Of have,apparently
R6884 T10327 T10324 arg2Of number,have
R6885 T10327 T10325 arg1Of number,a
R6886 T10327 T10326 arg1Of number,lower
R6887 T10327 T10328 arg1Of number,of
R6888 T10331 T10329 arg1Of cells,cytotoxic
R6889 T10331 T10330 arg1Of cells,T
R6890 T10331 T10332 arg1Of cells,(
R6891 T10331 T10338 arg1Of cells,and
R6892 T10336 T10332 arg2Of cells,(
R6893 T10336 T10333 arg1Of cells,CD8+positive
R6894 T10336 T10334 arg1Of cells,T
R6895 T10336 T10335 arg1Of cells,Lymphocytes
R6896 T10337 T10332 arg3Of ),(
R6897 T10338 T10328 arg2Of and,of
R6898 T10338 T10354 arg1Of and,","
R6899 T10338 T10355 arg1Of and,in
R6900 T10341 T10339 arg1Of cells,natural
R6901 T10341 T10340 arg1Of cells,killer
R6902 T10341 T10342 arg1Of cells,(
R6903 T10341 T10351 arg1Of cells,as
R6904 T10346 T10342 arg2Of cells,(
R6905 T10346 T10343 arg1Of cells,CD57
R6906 T10346 T10344 arg1Of cells,positive
R6907 T10346 T10345 arg1Of cells,NK
R6908 T10347 T10342 arg3Of ),(
R6909 T10351 T10338 arg2Of as,and
R6910 T10351 T10348 arg1Of as,","
R6911 T10351 T10349 arg1Of as,as
R6912 T10351 T10350 arg1Of as,well
R6913 T10353 T10351 arg2Of cells,as
R6914 T10353 T10352 arg1Of cells,dendrite
R6915 T10357 T10355 arg2Of tissues,in
R6916 T10357 T10356 arg1Of tissues,spleen
R6917 T10357 T10358 arg2Of tissues,compared
R6918 T10358 T10359 arg1Of compared,to
R6919 T10360 T10359 arg2Of those,to
R6920 T10360 T10361 arg1Of those,without
R6921 T10363 T10361 arg2Of cells,without
R6922 T10363 T10362 arg1Of cells,melanoma
R6923 T10366 T10365 arg1Of lymphocytes,the
R6924 T10366 T10367 arg1Of lymphocytes,of
R6925 T10366 T10371 arg1Of lymphocytes,did
R6926 T10366 T10373 arg1Of lymphocytes,decrease
R6927 T10370 T10367 arg2Of mice,of
R6928 T10370 T10368 arg1Of mice,the
R6929 T10370 T10369 arg1Of mice,CCR5−/−
R6930 T10373 T10364 arg1Of decrease,But
R6931 T10373 T10371 arg2Of decrease,did
R6932 T10373 T10372 arg1Of decrease,not
R6933 T10373 T10374 arg1Of decrease,when
R6934 T10375 T10374 arg2Of injected,when
R6935 T10375 T10376 arg1Of injected,with
R6936 T10378 T10376 arg2Of cells,with
R6937 T10378 T10377 arg1Of cells,melanoma
R6938 T10380 T10379 arg1Of differences,These
R6939 T10380 T10381 arg1Of differences,of
R6940 T10380 T10393 arg1Of differences,","
R6941 T10380 T10394 arg1Of differences,involving
R6942 T10380 T10399 arg1Of differences,may
R6943 T10380 T10400 arg1Of differences,be
R6944 T10380 T10401 arg2Of differences,connected
R6945 T10384 T10381 arg2Of response,of
R6946 T10384 T10382 arg1Of response,the
R6947 T10384 T10383 arg1Of response,immune
R6948 T10384 T10385 arg1Of response,between
R6949 T10388 T10386 arg1Of mice,the
R6950 T10388 T10387 arg1Of mice,CCR5+/+
R6951 T10388 T10389 arg1Of mice,and
R6952 T10389 T10385 arg2Of and,between
R6953 T10392 T10389 arg2Of mice,and
R6954 T10392 T10390 arg1Of mice,the
R6955 T10392 T10391 arg1Of mice,CCR5−/−
R6956 T10397 T10394 arg2Of tolerance,involving
R6957 T10397 T10395 arg1Of tolerance,tumor
R6958 T10397 T10396 arg1Of tolerance,immune
R6959 T10401 T10398 arg1Of connected,","
R6960 T10401 T10399 arg2Of connected,may
R6961 T10401 T10400 arg2Of connected,be
R6962 T10401 T10402 arg1Of connected,with
R6963 T10404 T10402 arg2Of inhibition,with
R6964 T10404 T10403 arg1Of inhibition,the
R6965 T10404 T10405 arg1Of inhibition,of
R6966 T10407 T10405 arg2Of progression,of
R6967 T10407 T10406 arg1Of progression,cancer
R6968 T10408 T10409 arg1Of Taken,together
R6969 T10415 T10411 arg2Of experiment,in
R6970 T10415 T10412 arg1Of experiment,the
R6971 T10415 T10413 arg1Of experiment,cytokine
R6972 T10415 T10414 arg1Of experiment,array
R6973 T10418 T10417 arg1Of level,the
R6974 T10418 T10419 arg1Of level,of
R6975 T10418 T10435 arg1Of level,was
R6976 T10418 T10436 arg2Of level,increased
R6977 T10420 T10419 arg2Of MIP-1α,of
R6978 T10420 T10421 arg1Of MIP-1α,(
R6979 T10422 T10421 arg2Of which,(
R6980 T10422 T10423 arg1Of which,has
R6981 T10426 T10423 arg2Of activity,has
R6982 T10426 T10424 arg1Of activity,a
R6983 T10426 T10425 arg1Of activity,potent
R6984 T10426 T10427 arg1Of activity,of
R6985 T10429 T10430 arg1Of cell,and
R6986 T10431 T10430 arg2Of B,and
R6987 T10433 T10427 arg2Of migration,of
R6988 T10433 T10428 arg1Of migration,T
R6989 T10433 T10429 arg1Of migration,cell
R6990 T10433 T10431 arg1Of migration,B
R6991 T10433 T10432 arg1Of migration,cell
R6992 T10434 T10421 arg3Of ),(
R6993 T10436 T10408 modOf increased,Taken
R6994 T10436 T10410 arg1Of increased,","
R6995 T10436 T10411 arg1Of increased,in
R6996 T10436 T10416 arg1Of increased,","
R6997 T10436 T10435 arg2Of increased,was
R6998 T10436 T10437 arg1Of increased,in
R6999 T10440 T10437 arg2Of mice,in
R7000 T10440 T10438 arg1Of mice,the
R7001 T10440 T10439 arg1Of mice,CCR5−/−
R7002 T10440 T10441 arg2Of mice,compared
R7003 T10441 T10442 arg1Of compared,with
R7004 T10443 T10442 arg2Of those,with
R7005 T10443 T10444 arg1Of those,in
R7006 T10447 T10444 arg2Of mice,in
R7007 T10447 T10445 arg1Of mice,the
R7008 T10447 T10446 arg1Of mice,CCR5+/+
R7009 T10451 T10450 arg1Of increased,relatively
R7010 T10455 T10451 arg1Of lymphocytes,increased
R7011 T10455 T10452 arg1Of lymphocytes,tumor
R7012 T10455 T10453 arg2Of lymphocytes,associated
R7013 T10455 T10454 arg1Of lymphocytes,cytotoxic
R7014 T10455 T10456 arg1Of lymphocytes,could
R7015 T10455 T10457 arg1Of lymphocytes,play
R7016 T10457 T10448 arg1Of play,Thus
R7017 T10457 T10449 arg1Of play,","
R7018 T10457 T10456 arg2Of play,could
R7019 T10457 T10461 arg1Of play,in
R7020 T10460 T10457 arg2Of role,play
R7021 T10460 T10458 arg1Of role,an
R7022 T10460 T10459 arg1Of role,important
R7023 T10462 T10461 arg2Of inhibiting,in
R7024 T10465 T10462 arg2Of growth,inhibiting
R7025 T10465 T10463 arg1Of growth,the
R7026 T10465 T10464 arg1Of growth,tumor
R7027 T10465 T10466 arg1Of growth,in
R7028 T10468 T10466 arg2Of mice,in
R7029 T10468 T10467 arg1Of mice,CCR5−/−

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T9205 1748-1752 Protein denotes CCR5
T9204 1605-1609 Protein denotes CCR5
T9203 1565-1569 Protein denotes CCR5
T9202 1476-1482 Protein denotes MIP-1α
T9201 1305-1309 Protein denotes CCR5
T9200 1284-1288 Protein denotes CCR5
T9199 1166-1170 Protein denotes CCR5
T9198 872-876 Protein denotes CCR5
T9197 761-765 Protein denotes CCR5
T9196 557-561 Protein denotes CCR5
T9195 491-495 Protein denotes CCL5
T9194 456-460 Protein denotes CCL5
T9193 451-455 Protein denotes CCR5
T9192 305-309 Protein denotes CCR5
T9191 190-194 Protein denotes CCR5
T9190 128-132 Protein denotes CCR5
T9189 101-105 Protein denotes CCR5
T9188 0-4 Protein denotes CCR5

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T10938 1476-1482 http://www.uniprot.org/uniprot/P10147 denotes MIP-1α
T10926 967-970 http://www.uniprot.org/uniprot/P10966 denotes CD8
T10924 967-970 http://www.uniprot.org/uniprot/P01732 denotes CD8
T10896 1748-1752 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10895 1605-1609 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10894 1565-1569 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10893 1305-1309 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10892 1284-1288 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10891 1166-1170 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10890 872-876 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10889 761-765 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10888 557-561 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10887 451-455 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10886 305-309 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10885 190-194 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10884 128-132 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10883 101-105 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10882 0-4 http://www.uniprot.org/uniprot/P51681 denotes CCR5

UBERON-AE

Id Subject Object Predicate Lexical cue
T9007 1082-1088 http://purl.obolibrary.org/obo/UBERON_0002106 denotes spleen
T9005 1089-1096 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues

GO-BP

Id Subject Object Predicate Lexical cue
T9284 994-1019 http://purl.obolibrary.org/obo/GO_0001770 denotes cells) and natural killer
T9283 994-1019 http://purl.obolibrary.org/obo/GO_0001779 denotes cells) and natural killer
T9282 994-1019 http://purl.obolibrary.org/obo/GO_0070246 denotes cells) and natural killer
T9281 994-1019 http://purl.obolibrary.org/obo/GO_0030101 denotes cells) and natural killer
T9280 994-1019 http://purl.obolibrary.org/obo/GO_0035747 denotes cells) and natural killer
T9279 994-1019 http://purl.obolibrary.org/obo/GO_0043320 denotes cells) and natural killer
T9278 994-1019 http://purl.obolibrary.org/obo/GO_0001787 denotes cells) and natural killer
T9277 1528-1542 http://purl.obolibrary.org/obo/GO_0016477 denotes cell migration
T9276 610-626 http://purl.obolibrary.org/obo/GO_0016477 denotes cells) migration
T9275 491-506 http://purl.obolibrary.org/obo/GO_0071609 denotes CCL5 production
T9274 375-387 http://purl.obolibrary.org/obo/GO_0009293 denotes transduction
T9271 461-470 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T9249 1256-1271 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T9248 345-360 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T9247 202-217 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T9229 1738-1744 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T9228 751-757 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T9227 21-27 http://purl.obolibrary.org/obo/GO_0040007 denotes growth

GO-CC

Id Subject Object Predicate Lexical cue
T9304 1224-1229 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9303 1132-1137 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9302 1072-1077 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9301 1044-1049 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9300 1020-1025 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9299 994-999 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9298 960-965 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9297 908-913 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9296 610-615 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9295 516-521 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9314 1063-1071 http://purl.obolibrary.org/obo/GO_0030425 denotes dendrite
T9313 76-84 http://purl.obolibrary.org/obo/GO_0030425 denotes dendrite

sentences

Id Subject Object Predicate Lexical cue
T9046 1619-1761 Sentence denotes Thus, relatively increased tumor associated cytotoxic lymphocytes could play an important role in inhibiting the tumor growth in CCR5−/− mice.
T9045 1413-1618 Sentence denotes Taken together, in the cytokine array experiment, the level of MIP-1α (which has a potent activity of T cell and B cell migration) was increased in the CCR5−/− mice compared with those in the CCR5+/+ mice.
T9044 1231-1412 Sentence denotes These differences of the immune response between the CCR5+/+ mice and the CCR5−/− mice, involving tumor immune tolerance, may be connected with the inhibition of cancer progression.
T9043 1139-1230 Sentence denotes But the lymphocytes of the CCR5−/− mice did not decrease when injected with melanoma cells.
T9042 829-1138 Sentence denotes Similar to this finding, we found that the CCR5+/+ mice injected with melanoma cells apparently have a lower number of cytotoxic T cells (CD8+positive T Lymphocytes cells) and natural killer cells (CD57 positive NK cells), as well as dendrite cells, in spleen tissues compared to those without melanoma cells.
T9041 685-828 Sentence denotes These data support the important premise that inhibition of tumor growth in CCR5−/− mice could be related with the inhibition of immune escape.
T9040 394-684 Sentence denotes Additionally, Tan MC et al. suggested that disruption of CCR5/CCL5 signaling, either by reducing CCL5 production by tumor cells or by systemic administration of a CCR5 inhibitor (TAK-779), reduced Treg (regulatory T cells) migration to tumors so that tumors are smaller in control mice [9].
T9039 289-393 Sentence denotes They found that CCR5 absence does not prevent the local immune response to adenovirus transduction [48].
T9038 147-288 Sentence denotes Cheng J and Sung RS examined the effect of CCR5 on the immune response to adenovirus vectors and graft function in an islet transplant model.
T9037 0-146 Sentence denotes CCR5 increases tumor growth in a local model and inhibits the efficacy of a dendrite cell vaccine in CCR5+/+ mice compared with CCR5−/− mice [10].
T179 0-146 Sentence denotes CCR5 increases tumor growth in a local model and inhibits the efficacy of a dendrite cell vaccine in CCR5+/+ mice compared with CCR5−/− mice [10].
T180 147-288 Sentence denotes Cheng J and Sung RS examined the effect of CCR5 on the immune response to adenovirus vectors and graft function in an islet transplant model.
T181 289-393 Sentence denotes They found that CCR5 absence does not prevent the local immune response to adenovirus transduction [48].
T182 394-684 Sentence denotes Additionally, Tan MC et al. suggested that disruption of CCR5/CCL5 signaling, either by reducing CCL5 production by tumor cells or by systemic administration of a CCR5 inhibitor (TAK-779), reduced Treg (regulatory T cells) migration to tumors so that tumors are smaller in control mice [9].
T183 685-828 Sentence denotes These data support the important premise that inhibition of tumor growth in CCR5−/− mice could be related with the inhibition of immune escape.
T184 829-1138 Sentence denotes Similar to this finding, we found that the CCR5+/+ mice injected with melanoma cells apparently have a lower number of cytotoxic T cells (CD8+positive T Lymphocytes cells) and natural killer cells (CD57 positive NK cells), as well as dendrite cells, in spleen tissues compared to those without melanoma cells.
T185 1139-1230 Sentence denotes But the lymphocytes of the CCR5−/− mice did not decrease when injected with melanoma cells.
T186 1231-1412 Sentence denotes These differences of the immune response between the CCR5+/+ mice and the CCR5−/− mice, involving tumor immune tolerance, may be connected with the inhibition of cancer progression.
T187 1413-1618 Sentence denotes Taken together, in the cytokine array experiment, the level of MIP-1α (which has a potent activity of T cell and B cell migration) was increased in the CCR5−/− mice compared with those in the CCR5+/+ mice.
T188 1619-1761 Sentence denotes Thus, relatively increased tumor associated cytotoxic lymphocytes could play an important role in inhibiting the tumor growth in CCR5−/− mice.

simple1

Id Subject Object Predicate Lexical cue
T9398 1748-1752 Protein denotes CCR5
T9397 1605-1609 Protein denotes CCR5
T9396 1565-1569 Protein denotes CCR5
T9395 1476-1482 Protein denotes MIP-1α
T9394 1305-1309 Protein denotes CCR5
T9393 1284-1288 Protein denotes CCR5
T9392 1166-1170 Protein denotes CCR5
T9391 872-876 Protein denotes CCR5
T9390 761-765 Protein denotes CCR5
T9389 557-561 Protein denotes CCR5
T9388 491-495 Protein denotes CCL5
T9387 456-460 Protein denotes CCL5
T9386 451-455 Protein denotes CCR5
T9385 305-309 Protein denotes CCR5
T9384 190-194 Protein denotes CCR5
T9383 128-132 Protein denotes CCR5
T9382 101-105 Protein denotes CCR5
T9381 0-4 Protein denotes CCR5

DLUT931

Id Subject Object Predicate Lexical cue
T11023 1548-1557 Positive_regulation denotes increased
T11022 482-490 Negative_regulation denotes reducing
T11021 562-571 Negative_regulation denotes inhibitor
T11020 496-506 Gene_expression denotes production
T11019 437-447 Negative_regulation denotes disruption
T11018 310-317 Negative_regulation denotes absence
T10987 1748-1752 Protein denotes CCR5
T10986 1605-1609 Protein denotes CCR5
T10985 1565-1569 Protein denotes CCR5
T10984 1476-1482 Protein denotes MIP-1α
T10983 1305-1309 Protein denotes CCR5
T10982 1284-1288 Protein denotes CCR5
T10981 1166-1170 Protein denotes CCR5
T10980 872-876 Protein denotes CCR5
T10979 761-765 Protein denotes CCR5
T10978 557-561 Protein denotes CCR5
T10977 491-495 Protein denotes CCL5
T10976 456-460 Protein denotes CCL5
T10975 451-455 Protein denotes CCR5
T10974 305-309 Protein denotes CCR5
T10973 190-194 Protein denotes CCR5
T10972 128-132 Protein denotes CCR5
T10971 101-105 Protein denotes CCR5
T10970 0-4 Protein denotes CCR5
R7352 T11020 T11022 themeOf production,reducing
R7353 T10974 T11018 themeOf CCR5,absence
R7354 T10975 T11019 themeOf CCR5,disruption
R7355 T11022 T11019 themeOf reducing,disruption
R7356 T10976 T11019 themeOf CCL5,disruption
R7357 T10977 T11020 themeOf CCL5,production
R7358 T10978 T11021 themeOf CCR5,inhibitor
R7361 T10984 T11023 themeOf MIP-1α,increased

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T11677 482-521 Negative_regulation denotes reducing CCL5 production by tumor cells
T11666 1548-1617 Protein denotes increased in the CCR5−/− mice compared with those in the CCR5+/+ mice
T11665 1143-1178 Entity denotes the lymphocytes of the CCR5−/− mice
T11653 1301-1318 Protein denotes the CCR5−/− mice,
T11647 971-999 Entity denotes positive T Lymphocytes cells
T11645 1625-1684 Entity denotes relatively increased tumor associated cytotoxic lymphocytes
T11643 76-84 Entity denotes dendrite
T11641 557-571 Entity denotes CCR5 inhibitor
T11640 945-965 Entity denotes of cytotoxic T cells
T11636 164-166 Protein denotes RS
T11630 1515-1521 Entity denotes T cell
T11621 109-113 Protein denotes mice
T11615 136-145 Protein denotes mice [10]
T11612 187-194 Protein denotes of CCR5
T11608 71-97 Entity denotes of a dendrite cell vaccine
T11597 1162-1178 Protein denotes the CCR5−/− mice
T11596 451-460 Protein denotes CCR5/CCL5
T11595 1476-1482 Protein denotes MIP-1α
T11593 71-97 Entity denotes of a dendrite cell vaccine
T11590 1215-1229 Entity denotes melanoma cells
T11583 1123-1137 Entity denotes melanoma cells
T11581 880-884 Protein denotes mice
T11578 1032-1049 Entity denotes positive NK cells
T11576 1280-1296 Protein denotes the CCR5+/+ mice
T11575 583-595 Entity denotes reduced Treg
T11570 451-460 Protein denotes CCR5/CCL5
T11568 1063-1077 Entity denotes dendrite cells
T11567 1063-1071 Entity denotes dendrite
T11565 761-773 Protein denotes CCR5−/− mice
T11563 1005-1025 Entity denotes natural killer cells
T11558 971-999 Entity denotes positive T Lymphocytes cells
T11555 667-683 Protein denotes control mice [9]
T11552 1663-1672 Entity denotes cytotoxic
T11540 597-615 Entity denotes regulatory T cells
T11539 456-460 Protein denotes CCL5
T11538 1601-1617 Protein denotes the CCR5+/+ mice
T11532 1754-1760 Protein denotes − mice
T11531 0-4 Protein denotes CCR5
T11530 510-521 Entity denotes tumor cells
T11526 491-495 Protein denotes CCL5
T11521 967-970 Protein denotes CD8
T11520 1432-1462 Protein denotes the cytokine array experiment,
T11513 408-414 Protein denotes Tan MC
T11507 305-309 Protein denotes CCR5
T11504 408-411 Entity denotes Tan
T11497 557-561 Protein denotes CCR5
T11689 448-471 Positive_regulation denotes of CCR5/CCL5 signaling,
T11685 437-527 Negative_regulation denotes disruption of CCR5/CCL5 signaling, either by reducing CCL5 production by tumor cells or by
T11681 491-506 Gene_expression denotes CCL5 production
R7559 T11526 T11681 themeOf CCL5,CCL5 production
R7573 T11596 T11689 causeOf CCR5/CCL5,"of CCR5/CCL5 signaling,"
R7580 T11681 T11677 themeOf CCL5 production,reducing CCL5 production by tumor cells
R7583 T11689 T11685 themeOf "of CCR5/CCL5 signaling,","disruption of CCR5/CCL5 signaling, either by reducing CCL5 production by tumor cells or by"

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T12856 1760-1761 . denotes .
T12855 1756-1760 NNS denotes mice
T12854 1754-1755 NN denotes −
T12853 1753-1754 NN denotes /
T12852 1752-1753 CD denotes −
T12851 1748-1752 CD denotes CCR5
T12850 1745-1747 IN denotes in
T12849 1738-1744 NN denotes growth
T12848 1732-1737 NN denotes tumor
T12847 1728-1731 DT denotes the
T12846 1717-1727 VBG denotes inhibiting
T12845 1714-1716 IN denotes in
T12844 1709-1713 NN denotes role
T12843 1699-1708 JJ denotes important
T12842 1696-1698 DT denotes an
T12841 1691-1695 VB denotes play
T12840 1685-1690 MD denotes could
T12839 1673-1684 NNS denotes lymphocytes
T12838 1663-1672 JJ denotes cytotoxic
T12837 1652-1662 VBN denotes associated
T12836 1646-1651 NN denotes tumor
T12835 1636-1645 VBD denotes increased
T12834 1625-1635 RB denotes relatively
T12833 1623-1624 , denotes ,
T12832 1619-1623 RB denotes Thus
T12831 1617-1618 . denotes .
T12830 1613-1617 NNS denotes mice
T12829 1611-1612 CD denotes +
T12828 1610-1611 VBD denotes /
T12827 1609-1610 NNP denotes +
T12826 1605-1609 NNP denotes CCR5
T12825 1601-1604 DT denotes the
T12824 1598-1600 IN denotes in
T12823 1592-1597 DT denotes those
T12822 1587-1591 IN denotes with
T12821 1578-1586 VBN denotes compared
T12820 1573-1577 NNS denotes mice
T12819 1571-1572 CD denotes −
T12818 1570-1571 VBD denotes /
T12817 1569-1570 NNP denotes −
T12816 1565-1569 NNP denotes CCR5
T12815 1561-1564 DT denotes the
T12814 1558-1560 IN denotes in
T12813 1548-1557 VBN denotes increased
T12812 1544-1547 VBD denotes was
T12811 1542-1543 -RRB- denotes )
T12810 1533-1542 NN denotes migration
T12809 1528-1532 NN denotes cell
T12808 1526-1527 NNP denotes B
T12807 1522-1525 CC denotes and
T12806 1517-1521 NN denotes cell
T12805 1515-1516 NNP denotes T
T12804 1512-1514 IN denotes of
T12803 1503-1511 NN denotes activity
T12802 1496-1502 JJ denotes potent
T12801 1494-1495 DT denotes a
T12800 1490-1493 VBZ denotes has
T12799 1484-1489 WDT denotes which
T12798 1483-1484 -LRB- denotes (
T12797 1476-1482 NNP denotes MIP-1α
T12796 1473-1475 IN denotes of
T12795 1467-1472 NN denotes level
T12794 1463-1466 DT denotes the
T12793 1461-1462 , denotes ,
T12792 1451-1461 NN denotes experiment
T12791 1445-1450 NN denotes array
T12790 1436-1444 NN denotes cytokine
T12789 1432-1435 DT denotes the
T12788 1429-1431 IN denotes in
T12787 1427-1428 , denotes ,
T12786 1419-1427 RB denotes together
T12785 1413-1418 VBN denotes Taken
T12784 1411-1412 . denotes .
T12783 1400-1411 NN denotes progression
T12782 1393-1399 NN denotes cancer
T12781 1390-1392 IN denotes of
T12780 1379-1389 NN denotes inhibition
T12779 1375-1378 DT denotes the
T12778 1370-1374 IN denotes with
T12777 1360-1369 VBN denotes connected
T12776 1357-1359 VB denotes be
T12775 1353-1356 MD denotes may
T12774 1351-1352 , denotes ,
T12773 1342-1351 NN denotes tolerance
T12769 1317-1318 , denotes ,
T12768 1313-1317 NNS denotes mice
T12767 1311-1312 CD denotes −
T12766 1310-1311 VBD denotes /
T12765 1309-1310 NNP denotes −
T12764 1305-1309 NNP denotes CCR5
T12763 1301-1304 DT denotes the
T12762 1297-1300 CC denotes and
T12761 1292-1296 NNS denotes mice
T12760 1290-1291 CD denotes +
T12759 1289-1290 VBD denotes /
T12758 1288-1289 NNP denotes +
T12757 1284-1288 NNP denotes CCR5
T12756 1280-1283 DT denotes the
T12755 1272-1279 IN denotes between
T12754 1263-1271 NN denotes response
T12753 1256-1262 JJ denotes immune
T12752 1252-1255 DT denotes the
T12751 1249-1251 IN denotes of
T12750 1237-1248 NNS denotes differences
T12749 1231-1236 DT denotes These
T12748 1229-1230 . denotes .
T12747 1224-1229 NNS denotes cells
T12746 1215-1223 NN denotes melanoma
T12745 1210-1214 IN denotes with
T12744 1201-1209 VBN denotes injected
T12743 1196-1200 WRB denotes when
T12742 1187-1195 VB denotes decrease
T12741 1183-1186 RB denotes not
T12740 1179-1182 VBD denotes did
T12739 1174-1178 NNS denotes mice
T12738 1172-1173 CD denotes −
T12737 1171-1172 VBD denotes /
T12736 1170-1171 NNP denotes −
T12735 1166-1170 NNP denotes CCR5
T12734 1162-1165 DT denotes the
T12733 1159-1161 IN denotes of
T12732 1147-1158 NNS denotes lymphocytes
T12731 1143-1146 DT denotes the
T12730 1139-1142 CC denotes But
T12729 1137-1138 . denotes .
T12728 1132-1137 NNS denotes cells
T12727 1123-1131 NN denotes melanoma
T12726 1115-1122 IN denotes without
T12725 1109-1114 DT denotes those
T12724 1106-1108 TO denotes to
T12723 1097-1105 VBN denotes compared
T12722 1089-1096 NNS denotes tissues
T12721 1082-1088 JJ denotes spleen
T12720 1079-1081 IN denotes in
T12719 1077-1078 , denotes ,
T12718 1072-1077 NNS denotes cells
T12717 1063-1071 JJ denotes dendrite
T12716 1060-1062 IN denotes as
T12715 1055-1059 RB denotes well
T12714 1052-1054 RB denotes as
T12713 1050-1051 , denotes ,
T12712 1049-1050 -RRB- denotes )
T12711 1044-1049 NNS denotes cells
T12710 1041-1043 NNP denotes NK
T12709 1032-1040 JJ denotes positive
T12708 1027-1031 NNP denotes CD57
T12707 1026-1027 -LRB- denotes (
T12706 1020-1025 NNS denotes cells
T12705 1013-1019 NN denotes killer
T12704 1005-1012 JJ denotes natural
T12703 1001-1004 CC denotes and
T12702 999-1000 -RRB- denotes )
T12701 994-999 NNS denotes cells
T12700 982-993 NNP denotes Lymphocytes
T12699 980-981 NNP denotes T
T12698 971-979 JJ denotes positive
T12697 970-971 NN denotes +
T12696 967-970 CD denotes CD8
T12695 966-967 -LRB- denotes (
T12694 960-965 NNS denotes cells
T12693 958-959 NNP denotes T
T12692 948-957 JJ denotes cytotoxic
T12691 945-947 IN denotes of
T12690 938-944 NN denotes number
T12689 932-937 JJR denotes lower
T12688 930-931 DT denotes a
T12687 925-929 VBP denotes have
T12686 914-924 RB denotes apparently
T12685 908-913 NNS denotes cells
T12684 899-907 NN denotes melanoma
T12683 894-898 IN denotes with
T12682 885-893 VBN denotes injected
T12681 880-884 NNS denotes mice
T12680 878-879 CD denotes +
T12679 877-878 VBD denotes /
T12678 876-877 NNP denotes +
T12677 872-876 NNP denotes CCR5
T12676 868-871 DT denotes the
T12675 863-867 IN denotes that
T12674 857-862 VBD denotes found
T12673 854-856 PRP denotes we
T12672 852-853 , denotes ,
T12671 845-852 NN denotes finding
T12670 840-844 DT denotes this
T12669 837-839 TO denotes to
T12668 829-836 JJ denotes Similar
T12667 827-828 . denotes .
T12666 821-827 NN denotes escape
T12665 814-820 JJ denotes immune
T12664 811-813 IN denotes of
T12663 800-810 NN denotes inhibition
T12662 796-799 DT denotes the
T12661 791-795 IN denotes with
T12660 783-790 VBN denotes related
T12659 780-782 VB denotes be
T12658 774-779 MD denotes could
T12657 769-773 NNS denotes mice
T12656 767-768 NN denotes −
T12655 766-767 NN denotes /
T12654 765-766 CD denotes −
T12653 761-765 CD denotes CCR5
T12652 758-760 IN denotes in
T12651 751-757 NN denotes growth
T12650 745-750 NN denotes tumor
T12649 742-744 IN denotes of
T12648 731-741 NN denotes inhibition
T12647 726-730 WDT denotes that
T12646 718-725 NN denotes premise
T12645 708-717 JJ denotes important
T12644 704-707 DT denotes the
T12643 696-703 VBP denotes support
T12642 691-695 NNS denotes data
T12641 685-690 DT denotes These
T12640 683-684 . denotes .
T12639 682-683 NNP denotes ]
T12638 681-682 CD denotes 9
T12637 680-681 VBP denotes [
T12636 675-679 NNS denotes mice
T12635 667-674 NN denotes control
T12634 664-666 IN denotes in
T12633 656-663 JJR denotes smaller
T12632 652-655 VBP denotes are
T12631 645-651 NNS denotes tumors
T12630 640-644 IN denotes that
T12629 637-639 IN denotes so
T12628 630-636 NNS denotes tumors
T12627 627-629 TO denotes to
T12626 617-626 NN denotes migration
T12625 615-616 -RRB- denotes )
T12624 610-615 NNS denotes cells
T12623 608-609 NNP denotes T
T12622 597-607 JJ denotes regulatory
T12621 596-597 -LRB- denotes (
T12620 591-595 NNP denotes Treg
T12619 583-590 VBN denotes reduced
T12618 581-582 , denotes ,
T12617 580-581 -RRB- denotes )
T12616 573-580 CD denotes TAK-779
T12615 572-573 -LRB- denotes (
T12614 562-571 NN denotes inhibitor
T12613 557-561 NNP denotes CCR5
T12612 555-556 DT denotes a
T12611 552-554 IN denotes of
T12610 537-551 NN denotes administration
T12609 528-536 JJ denotes systemic
T12608 525-527 IN denotes by
T12607 522-524 CC denotes or
T12606 516-521 NNS denotes cells
T12605 510-515 NN denotes tumor
T12604 507-509 IN denotes by
T12603 496-506 NN denotes production
T12602 491-495 CD denotes CCL5
T12601 482-490 VBG denotes reducing
T12600 479-481 IN denotes by
T12599 472-478 RB denotes either
T12598 470-471 , denotes ,
T12597 461-470 VBG denotes signaling
T12596 451-460 CD denotes CCR5/CCL5
T12595 448-450 IN denotes of
T12594 437-447 NN denotes disruption
T12593 432-436 IN denotes that
T12592 422-431 VBD denotes suggested
T12591 418-421 FW denotes al.
T12590 415-417 FW denotes et
T12589 412-414 NNP denotes MC
T12588 408-411 NNP denotes Tan
T12587 406-407 , denotes ,
T12586 394-406 RB denotes Additionally
T12585 392-393 . denotes .
T12584 391-392 NNP denotes ]
T12583 389-391 CD denotes 48
T12582 388-389 NNP denotes [
T12581 375-387 NN denotes transduction
T12580 364-374 NN denotes adenovirus
T12579 361-363 TO denotes to
T12578 352-360 NN denotes response
T12577 345-351 JJ denotes immune
T12576 339-344 JJ denotes local
T12575 335-338 DT denotes the
T12574 327-334 VB denotes prevent
T12573 323-326 RB denotes not
T12572 318-322 VBZ denotes does
T12571 310-317 NN denotes absence
T12570 305-309 CD denotes CCR5
T12569 300-304 IN denotes that
T12568 294-299 VBD denotes found
T12567 289-293 PRP denotes They
T12566 287-288 . denotes .
T12565 282-287 NN denotes model
T12564 271-281 NN denotes transplant
T12563 265-270 NN denotes islet
T12562 262-264 DT denotes an
T12561 259-261 IN denotes in
T12560 250-258 NN denotes function
T12559 244-249 NN denotes graft
T12558 240-243 CC denotes and
T12557 232-239 NNS denotes vectors
T12556 221-231 NN denotes adenovirus
T12555 218-220 TO denotes to
T12554 209-217 NN denotes response
T12536 136-140 NNS denotes mice
T12535 134-135 NN denotes −
T12534 133-134 NN denotes /
T12533 132-133 CD denotes −
T12532 128-132 CD denotes CCR5
T12531 123-127 IN denotes with
T12772 1335-1341 JJ denotes immune
T12771 1329-1334 NN denotes tumor
T12770 1319-1328 VBG denotes involving
T12530 114-122 VBN denotes compared
T12529 109-113 NNS denotes mice
T12528 107-108 NN denotes +
T12527 106-107 NN denotes /
T12526 105-106 CD denotes +
T12525 101-105 CD denotes CCR5
T12524 98-100 IN denotes in
T12523 90-97 NN denotes vaccine
T12522 85-89 NN denotes cell
T12521 76-84 JJ denotes dendrite
T12520 74-75 DT denotes a
T12519 71-73 IN denotes of
T12518 62-70 NN denotes efficacy
T12517 58-61 DT denotes the
T12516 49-57 VBZ denotes inhibits
T12515 45-48 CC denotes and
T12514 39-44 NN denotes model
T12513 33-38 JJ denotes local
T12512 31-32 DT denotes a
T12511 28-30 IN denotes in
T12510 21-27 NN denotes growth
T12509 15-20 NN denotes tumor
T12508 5-14 NNS denotes increases
T12507 0-4 CD denotes CCR5
T12553 202-208 JJ denotes immune
T12552 198-201 DT denotes the
T12551 195-197 IN denotes on
T12550 190-194 NNS denotes CCR5
T12549 187-189 IN denotes of
T12548 180-186 NN denotes effect
T12547 176-179 DT denotes the
T12546 167-175 VBD denotes examined
T12545 164-166 NNP denotes RS
T12544 159-163 NNP denotes Sung
T12543 155-158 CC denotes and
T12542 153-154 NNP denotes J
T12541 147-152 NNP denotes Cheng
T12540 145-146 . denotes .
T12539 144-145 NNP denotes ]
T12538 142-144 CD denotes 10
T12537 141-142 NNP denotes [
R8371 T12507 T12508 nummod CCR5,increases
R8373 T12508 T12516 nsubj increases,inhibits
R8374 T12509 T12510 compound tumor,growth
R8375 T12510 T12508 dobj growth,increases
R8377 T12511 T12508 prep in,increases
R8378 T12512 T12514 det a,model
R8379 T12513 T12514 amod local,model
R8381 T12514 T12511 pobj model,in
R8382 T12515 T12508 cc and,increases
R8384 T12516 T12516 ROOT inhibits,inhibits
R8385 T12517 T12518 det the,efficacy
R8386 T12518 T12516 dobj efficacy,inhibits
R8388 T12519 T12518 prep of,efficacy
R8389 T12520 T12523 det a,vaccine
R8390 T12521 T12523 amod dendrite,vaccine
R8391 T12522 T12523 compound cell,vaccine
R8392 T12523 T12519 pobj vaccine,of
R8393 T12524 T12518 prep in,efficacy
R8395 T12525 T12529 nummod CCR5,mice
R8396 T12526 T12529 nummod +,mice
R8397 T12527 T12529 compound /,mice
R8399 T12528 T12529 compound +,mice
R8400 T12529 T12524 pobj mice,in
R8401 T12530 T12516 prep compared,inhibits
R8403 T12531 T12530 prep with,compared
R8404 T12532 T12536 nummod CCR5,mice
R8405 T12533 T12536 nummod −,mice
R8407 T12534 T12536 compound /,mice
R8408 T12535 T12536 compound −,mice
R8409 T12536 T12531 pobj mice,with
R8410 T12537 T12539 nmod [,]
R8412 T12538 T12539 nummod 10,]
R8413 T12539 T12536 appos ],mice
R8415 T12540 T12516 punct .,inhibits
R8416 T12541 T12542 compound Cheng,J
R8417 T12542 T12546 nsubj J,examined
R8419 T12543 T12542 cc and,J
R8420 T12544 T12542 conj Sung,J
R8421 T12545 T12542 conj RS,J
R8423 T12546 T12546 ROOT examined,examined
R8424 T12547 T12548 det the,effect
R8426 T12548 T12546 dobj effect,examined
R8427 T12549 T12548 prep of,effect
R8428 T12550 T12549 pobj CCR5,of
R8430 T12551 T12548 prep on,effect
R8431 T12552 T12554 det the,response
R8432 T12553 T12554 amod immune,response
R8434 T12554 T12551 pobj response,on
R8435 T12555 T12554 prep to,response
R8436 T12556 T12557 compound adenovirus,vectors
R8438 T12557 T12555 pobj vectors,to
R8439 T12558 T12557 cc and,vectors
R8440 T12559 T12560 compound graft,function
R8441 T12560 T12557 conj function,vectors
R8442 T12561 T12554 prep in,response
R8443 T12562 T12565 det an,model
R8445 T12563 T12565 compound islet,model
R8446 T12564 T12565 compound transplant,model
R8447 T12565 T12561 pobj model,in
R8450 T12566 T12546 punct .,examined
R8452 T12567 T12568 nsubj They,found
R8453 T12568 T12568 ROOT found,found
R8454 T12569 T12574 mark that,prevent
R8456 T12570 T12571 nummod CCR5,absence
R8457 T12571 T12574 nsubj absence,prevent
R8459 T12572 T12574 aux does,prevent
R8460 T12573 T12574 neg not,prevent
R8461 T12574 T12568 ccomp prevent,found
R8463 T12575 T12578 det the,response
R8464 T12576 T12578 amod local,response
R8466 T12577 T12578 amod immune,response
R8467 T12578 T12574 dobj response,prevent
R8468 T12579 T12580 aux to,adenovirus
R8470 T12580 T12574 advcl adenovirus,prevent
R8471 T12581 T12582 compound transduction,[
R8472 T12600 T12594 prep by,disruption
R8473 T12582 T12580 dobj [,adenovirus
R8474 T12583 T12584 nummod 48,]
R8475 T12584 T12582 appos ],[
R8476 T12585 T12568 punct .,found
R8477 T12586 T12592 advmod Additionally,suggested
R8478 T12601 T12600 pcomp reducing,by
R8479 T12587 T12592 punct ",",suggested
R8480 T12588 T12589 compound Tan,MC
R8481 T12589 T12591 compound MC,al.
R8482 T12602 T12603 nummod CCL5,production
R8483 T12590 T12591 compound et,al.
R8484 T12591 T12592 nsubj al.,suggested
R8485 T12592 T12592 ROOT suggested,suggested
R8486 T12593 T12619 mark that,reduced
R8487 T12603 T12601 dobj production,reducing
R8488 T12594 T12619 nsubj disruption,reduced
R8489 T12595 T12594 prep of,disruption
R8490 T12596 T12595 pobj CCR5/CCL5,of
R8491 T12597 T12594 acl signaling,disruption
R8492 T12598 T12597 punct ",",signaling
R8493 T12599 T12600 advmod either,by
R8494 T12604 T12603 prep by,production
R8495 T12605 T12606 compound tumor,cells
R8496 T12606 T12604 pobj cells,by
R8497 T12607 T12604 cc or,by
R8498 T12697 T12701 amod +,cells
R8499 T12698 T12701 amod positive,cells
R8500 T12608 T12604 conj by,by
R8501 T12699 T12700 compound T,Lymphocytes
R8502 T12700 T12701 compound Lymphocytes,cells
R8503 T12609 T12610 amod systemic,administration
R8504 T12701 T12694 appos cells,cells
R8505 T12702 T12694 punct ),cells
R8506 T12610 T12608 pobj administration,by
R8507 T12703 T12690 cc and,number
R8508 T12704 T12706 amod natural,cells
R8509 T12705 T12706 compound killer,cells
R8510 T12611 T12610 prep of,administration
R8511 T12706 T12690 conj cells,number
R8512 T12707 T12690 punct (,number
R8513 T12708 T12711 nmod CD57,cells
R8514 T12612 T12614 det a,inhibitor
R8515 T12709 T12711 amod positive,cells
R8516 T12710 T12711 compound NK,cells
R8517 T12711 T12690 appos cells,number
R8518 T12712 T12690 punct ),number
R8519 T12613 T12614 compound CCR5,inhibitor
R8520 T12713 T12690 punct ",",number
R8521 T12714 T12716 advmod as,as
R8522 T12614 T12611 pobj inhibitor,of
R8523 T12715 T12716 advmod well,as
R8524 T12716 T12690 cc as,number
R8525 T12717 T12718 amod dendrite,cells
R8526 T12615 T12614 punct (,inhibitor
R8527 T12718 T12690 conj cells,number
R8528 T12719 T12687 punct ",",have
R8529 T12720 T12687 prep in,have
R8530 T12616 T12614 appos TAK-779,inhibitor
R8531 T12721 T12722 compound spleen,tissues
R8532 T12617 T12614 punct ),inhibitor
R8533 T12722 T12720 pobj tissues,in
R8534 T12618 T12594 punct ",",disruption
R8535 T12723 T12687 prep compared,have
R8536 T12724 T12723 prep to,compared
R8537 T12619 T12592 ccomp reduced,suggested
R8538 T12725 T12724 pobj those,to
R8539 T12726 T12725 prep without,those
R8540 T12620 T12626 nmod Treg,migration
R8541 T12727 T12728 compound melanoma,cells
R8542 T12728 T12726 pobj cells,without
R8543 T12729 T12674 punct .,found
R8544 T12730 T12737 cc But,/
R8545 T12731 T12732 det the,lymphocytes
R8546 T12621 T12620 punct (,Treg
R8547 T12732 T12737 nsubj lymphocytes,/
R8548 T12733 T12732 prep of,lymphocytes
R8549 T12734 T12736 det the,−
R8550 T12735 T12736 compound CCR5,−
R8551 T12622 T12624 amod regulatory,cells
R8552 T12736 T12733 pobj −,of
R8553 T12737 T12737 ROOT /,/
R8554 T12623 T12624 compound T,cells
R8555 T12738 T12739 nummod −,mice
R8556 T12739 T12742 nsubj mice,decrease
R8557 T12740 T12742 aux did,decrease
R8558 T12624 T12620 appos cells,Treg
R8559 T12741 T12742 neg not,decrease
R8560 T12742 T12737 ccomp decrease,/
R8561 T12743 T12744 advmod when,injected
R8562 T12625 T12620 punct ),Treg
R8563 T12744 T12742 advcl injected,decrease
R8564 T12745 T12744 prep with,injected
R8565 T12746 T12747 compound melanoma,cells
R8566 T12747 T12745 pobj cells,with
R8567 T12626 T12619 dobj migration,reduced
R8568 T12748 T12737 punct .,/
R8569 T12749 T12750 det These,differences
R8570 T12627 T12619 prep to,reduced
R8571 T12750 T12759 nsubj differences,/
R8572 T12751 T12750 prep of,differences
R8573 T12752 T12754 det the,response
R8574 T12753 T12754 amod immune,response
R8575 T12628 T12627 pobj tumors,to
R8576 T12754 T12751 pobj response,of
R8577 T12755 T12754 prep between,response
R8578 T12629 T12632 mark so,are
R8579 T12756 T12758 det the,+
R8580 T12757 T12758 compound CCR5,+
R8581 T12758 T12755 pobj +,between
R8582 T12630 T12632 mark that,are
R8583 T12759 T12759 ROOT /,/
R8584 T12760 T12761 nummod +,mice
R8585 T12761 T12759 dobj mice,/
R8586 T12762 T12761 cc and,mice
R8587 T12631 T12632 nsubj tumors,are
R8588 T12763 T12765 det the,−
R8589 T12764 T12765 compound CCR5,−
R8590 T12765 T12766 nsubj −,/
R8591 T12766 T12759 conj /,/
R8592 T12767 T12768 nummod −,mice
R8593 T12768 T12766 dobj mice,/
R8594 T12632 T12619 advcl are,reduced
R8595 T12769 T12766 punct ",",/
R8596 T12770 T12766 advcl involving,/
R8597 T12771 T12772 npadvmod tumor,immune
R8598 T12772 T12773 amod immune,tolerance
R8599 T12633 T12632 acomp smaller,are
R8600 T12773 T12770 dobj tolerance,involving
R8601 T12774 T12777 punct ",",connected
R8602 T12775 T12777 aux may,connected
R8603 T12634 T12633 prep in,smaller
R8604 T12776 T12777 auxpass be,connected
R8605 T12777 T12759 conj connected,/
R8606 T12635 T12636 compound control,mice
R8607 T12778 T12777 prep with,connected
R8608 T12779 T12780 det the,inhibition
R8609 T12780 T12778 pobj inhibition,with
R8610 T12636 T12634 pobj mice,in
R8611 T12781 T12780 prep of,inhibition
R8612 T12782 T12783 compound cancer,progression
R8613 T12783 T12781 pobj progression,of
R8614 T12637 T12632 conj [,are
R8615 T12784 T12759 punct .,/
R8616 T12785 T12813 advcl Taken,increased
R8617 T12786 T12785 advmod together,Taken
R8618 T12638 T12639 nummod 9,]
R8619 T12787 T12785 punct ",",Taken
R8620 T12788 T12785 prep in,Taken
R8621 T12789 T12792 det the,experiment
R8622 T12639 T12637 appos ],[
R8623 T12790 T12792 compound cytokine,experiment
R8624 T12791 T12792 compound array,experiment
R8625 T12640 T12592 punct .,suggested
R8626 T12792 T12788 pobj experiment,in
R8627 T12793 T12813 punct ",",increased
R8628 T12641 T12642 det These,data
R8629 T12642 T12643 nsubj data,support
R8630 T12794 T12795 det the,level
R8631 T12643 T12643 ROOT support,support
R8632 T12795 T12813 nsubjpass level,increased
R8633 T12796 T12795 prep of,level
R8634 T12797 T12796 pobj MIP-1α,of
R8635 T12644 T12646 det the,premise
R8636 T12798 T12797 punct (,MIP-1α
R8637 T12799 T12800 nsubj which,has
R8638 T12645 T12646 amod important,premise
R8639 T12800 T12797 relcl has,MIP-1α
R8640 T12646 T12643 dobj premise,support
R8641 T12801 T12803 det a,activity
R8642 T12802 T12803 amod potent,activity
R8643 T12803 T12800 dobj activity,has
R8644 T12804 T12803 prep of,activity
R8645 T12805 T12806 compound T,cell
R8646 T12806 T12804 pobj cell,of
R8647 T12647 T12660 mark that,related
R8648 T12807 T12806 cc and,cell
R8649 T12808 T12809 compound B,cell
R8650 T12648 T12660 nsubjpass inhibition,related
R8651 T12809 T12810 compound cell,migration
R8652 T12810 T12806 conj migration,cell
R8653 T12811 T12797 punct ),MIP-1α
R8654 T12649 T12648 prep of,inhibition
R8655 T12812 T12813 auxpass was,increased
R8656 T12813 T12813 ROOT increased,increased
R8657 T12814 T12813 prep in,increased
R8658 T12650 T12651 compound tumor,growth
R8659 T12815 T12817 det the,−
R8660 T12816 T12817 compound CCR5,−
R8661 T12817 T12814 pobj −,in
R8662 T12651 T12649 pobj growth,of
R8663 T12818 T12813 advcl /,increased
R8664 T12819 T12820 nummod −,mice
R8665 T12820 T12818 dobj mice,/
R8666 T12652 T12648 prep in,inhibition
R8667 T12821 T12818 prep compared,/
R8668 T12822 T12821 prep with,compared
R8669 T12823 T12822 pobj those,with
R8670 T12653 T12657 nummod CCR5,mice
R8671 T12824 T12823 prep in,those
R8672 T12825 T12827 det the,+
R8673 T12826 T12827 compound CCR5,+
R8674 T12654 T12657 nummod −,mice
R8675 T12827 T12828 compound +,/
R8676 T12828 T12818 conj /,/
R8677 T12829 T12830 nummod +,mice
R8678 T12655 T12657 nmod /,mice
R8679 T12830 T12828 dobj mice,/
R8680 T12831 T12828 punct .,/
R8681 T12832 T12841 advmod Thus,play
R8682 T12656 T12657 compound −,mice
R8683 T12833 T12841 punct ",",play
R8684 T12834 T12835 advmod relatively,increased
R8685 T12835 T12839 amod increased,lymphocytes
R8686 T12657 T12652 pobj mice,in
R8687 T12836 T12839 nmod tumor,lymphocytes
R8688 T12837 T12839 amod associated,lymphocytes
R8689 T12838 T12839 compound cytotoxic,lymphocytes
R8690 T12658 T12660 aux could,related
R8691 T12839 T12841 nsubj lymphocytes,play
R8692 T12840 T12841 aux could,play
R8693 T12841 T12841 ROOT play,play
R8694 T12842 T12844 det an,role
R8695 T12843 T12844 amod important,role
R8696 T12844 T12841 dobj role,play
R8697 T12659 T12660 auxpass be,related
R8698 T12845 T12841 prep in,play
R8699 T12846 T12845 pcomp inhibiting,in
R8700 T12847 T12849 det the,growth
R8701 T12660 T12646 acl related,premise
R8702 T12848 T12849 compound tumor,growth
R8703 T12849 T12846 dobj growth,inhibiting
R8704 T12661 T12660 prep with,related
R8705 T12662 T12663 det the,inhibition
R8706 T12850 T12849 prep in,growth
R8707 T12851 T12855 nummod CCR5,mice
R8708 T12852 T12855 nummod −,mice
R8709 T12663 T12661 pobj inhibition,with
R8710 T12853 T12855 nmod /,mice
R8711 T12854 T12855 compound −,mice
R8712 T12855 T12850 pobj mice,in
R8713 T12664 T12663 prep of,inhibition
R8714 T12856 T12841 punct .,play
R8717 T12665 T12666 amod immune,escape
R8721 T12666 T12664 pobj escape,of
R8725 T12667 T12643 punct .,support
R8729 T12668 T12674 advmod Similar,found
R8733 T12669 T12668 prep to,Similar
R8737 T12670 T12671 det this,finding
R8741 T12671 T12669 pobj finding,to
R8743 T12672 T12674 punct ",",found
R8747 T12673 T12674 nsubj we,found
R8751 T12674 T12674 ROOT found,found
R8755 T12675 T12679 mark that,/
R8758 T12676 T12678 det the,+
R8761 T12677 T12678 compound CCR5,+
R8762 T12678 T12679 nsubj +,/
R8763 T12679 T12674 ccomp /,found
R8765 T12680 T12681 nummod +,mice
R8769 T12681 T12679 dobj mice,/
R8772 T12682 T12681 acl injected,mice
R8776 T12683 T12682 prep with,injected
R8780 T12684 T12685 compound melanoma,cells
R8784 T12685 T12687 nsubj cells,have
R8788 T12686 T12687 advmod apparently,have
R8795 T12687 T12674 ccomp have,found
R8800 T12688 T12690 det a,number
R8803 T12689 T12690 amod lower,number
R8807 T12690 T12687 dobj number,have
R8811 T12691 T12690 prep of,number
R8815 T12692 T12694 amod cytotoxic,cells
R8819 T12693 T12694 compound T,cells
R8822 T12694 T12691 pobj cells,of
R8826 T12695 T12694 punct (,cells
R8830 T12696 T12701 nummod CD8,cells

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T11318 1548-1557 Positive_regulation denotes increased
T11317 1476-1482 Protein denotes MIP-1α
T11316 1027-1031 Protein denotes CD57
T11315 967-970 Protein denotes CD8
T11314 482-490 Negative_regulation denotes reducing
T11313 496-506 Gene_expression denotes production
T11312 557-561 Protein denotes CCR5
T11311 491-495 Protein denotes CCL5
T11310 456-460 Protein denotes CCL5
T11309 451-455 Protein denotes CCR5
T11308 408-414 Protein denotes Tan MC
T11307 190-194 Protein denotes CCR5
T11306 0-4 Protein denotes CCR5
R7492 T11311 T11313 themeOf CCL5,production
R7494 T11313 T11314 themeOf production,reducing
R7496 T11317 T11318 themeOf MIP-1α,increased